Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin

  1. Lookup NU author(s)
  2. Dr David Sheridan
  3. Dr David Price
  4. Dr Matthias Schmid
  5. Professor Geoff Toms
  6. Dr Peter Donaldson
  7. Dr R Neely
  8. Professor Margaret Bassendine
Author(s)Sheridan DA, Price DA, Schmid ML, Toms GL, Donaldson P, Neely D, Bassendine MF
Publication type Article
JournalAlimentary Pharmacology & Therapeutics
Year2009
Volume29
Issue12
Pages1282-1290
ISSN (print)0269-2813
ISSN (electronic)1365-2036
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherWiley-Blackwell Publishing Ltd.
URLhttp://dx.doi.org/10.1111/j.1365-2036.2009.04012.x
DOI10.1111/j.1365-2036.2009.04012.x
Actions    Link to this publication